Leflunomide is a DMARD, used in active moderate to severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor.
Read more about Leflunomide: Basic Chemical, Pharmacological, and Marketing Data, Regular Indications, Orphan Drug Status, Other Potential Indications, Contraindications and Precautions, Malignancies, Side-effects, Interactions, Dosage Regimen, Necessary Laboratory Examinations, Patient Counselling, Summary and Safety Controversy